Literature DB >> 30105753

Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation.

Daniel Xia1,2, Eric D Hsi3, Paola Dal Cin4, Robert P Hasserjian1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30105753     DOI： 10.1002/ajh.25249

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  3 in total

Review 1.  Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review.

Authors:  Chunshui Liu; Ruiping Hu; Zhonghua Du; Manuel Abecasis; Cong Wang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

2.  Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm.

Authors:  Stephen E Langabeer
Journal:  EXCLI J       Date:  2020-01-08       Impact factor: 4.068

Review 3.  Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review.

Authors:  Seug Yun Yoon; Sun Young Jeong; Changgon Kim; Min-Young Lee; Jieun Kim; Kyoung-Ha Kim; Namsu Lee; Jong-Ho Won
Journal:  Cancer Res Treat       Date:  2020-01-15       Impact factor: 4.679
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.